Avatrombopag for Chemotherapy-induced Thrombocytopenia
Clinical trial NCT05218226 · UNKNOWN
Trial details
- NCT number
- NCT05218226
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2024-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.